• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number JHJR051502J
Device Problem Difficult to Open or Close (2921)
Patient Problem No Information (3190)
Event Date 06/27/2018
Event Type  Injury  
Manufacturer Narrative
Additional manufacturer narrative: review of the manufacturing records verified that the lot met release requirements.Examination of the returned device is in process.
 
Event Description
On (b)(6) 2018, the patient presented for an endovascular repair of an occlusion of the right superficial femoral artery using gore® viabahn® endoprosthesis with heparin bioactive surface.It was reported that during deployment the endoprosthesis partially expanded then ceased.The partially expanded endoprosthesis was manipulated to a place in the right groin where a cut down was performed and the entire device removed.
 
Manufacturer Narrative
Additional manufacturer narrative: examination of the returned device revealed the following: the device arrived in 3 separate pieces: the delivery catheter with part of the distal shaft (upon which the endoprosthesis was mounted), the deployment line connected to a deployment knob, and a partially expanded endoprosthesis mounted on a portion of the distal shaft; approximately 152 cm of deployment line was connected to the deployment knob; the distal shaft was broken/cut at 7 cm from the transition; approximately 1.7 cm of distal shaft was exposed on which the constrained endoprosthesis was mounted on; at 9.5 cm past the deployment line connected to constrained endoprosthesis, there were 2 fibers extending another 27.5 cm; there was approximately 7.5 cm of expanded endoprosthesis; the constrained endoprosthesis appeared to be bunched into expanded endoprosthesis; deployment could be continued with traction on the deployment line at endoprosthesis.Based on the device examination performed, no manufacturing anomalies were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key7715192
MDR Text Key114869689
Report Number2017233-2018-00423
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 08/10/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/27/2020
Device Catalogue NumberJHJR051502J
Device Lot Number16454003
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/16/2018
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received07/24/2018
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received08/15/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
-
-